Neuroprotective and pro-cognitive effects of Rosmarinus officinalis L. extracts and its biologically active compounds on induced neurodegenerative and neuroinflammatory processes in vitro and in vivo in context of Alzheimer’s disease. Current knowledge
Herba Polonica · 30.06.2026 · 72 (2) · 73-98
DOI: 10.5604/01.3001.0055.7332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Herba Polonica, erschienen am 30.06.2026. Verfasst von MARCIN OŻAROWSKI und 6 weiteren Autor:innen. Die Arbeit nennt 152 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
The prevention and treatment of neurodegenerative diseases are a critical global public health concern. The search for novel therapeutic strategies, including the development of new, innovative, effective, and safe medicinal products, as well as the elucidation of their mechanisms of action, represents a rapidly expanding area of scientific research. A promising medicinal plant that has generated renewed therapeutic interest recently is rosemary (Rosmarinus officinalis L.), which exhibits a wide spectrum of pharmacological activities. This review offers a concise overview of the current state of knowledge as it pertains to the neuroprotective potential of rosemary and its bioactive constituents, which include rosmarinic acid, carnosic acid, ursolic acid, carnosol, as well as essential oil fractions and aqueous-ethanolic and ethanolic extracts. These effects are characterized by the regulation of oxidative stress, inflammatory mediators, and the elevation of brain-derived neurotrophic factor and synaptic markers, as well as the inhibition of cholinesterases at the molecular, biochemical, and cellular levels. Moreover, it has been demonstrated that R. officinalis can reverse the harmful effects of β-amyloid, reduce the amnesic effects caused by scopolamine, and exhibit cytoprotective activity against a variety of neurotoxic substances of endogenous or environmental origin (xenobiotics), including paraquat (1,1′-dimethyl-4,4′-bipyridinium dichloride), acrylamide (ACR), aluminum chloride, bisphenol, lipopolysaccharides (LPS; e.g. from Salmonella spp. and Escherichia coli), and chlorpyrifos (an organophosphate pesticide). Analysis of the available clinical studies has also shown that administering rosemary improves a variety of memory types. The current state of knowledge was analysed using literature from PubMed, SCOPUS, and ScienceDirect (Elsevier).
Zitieren
APA
OŻAROWSKI, M., KARPIŃSKI, T., STYSZYŃSKI, F., URBANIAK, A., GRZYWNA, W., CHAVES, D. S. D. A., & SEREMAK-MROZIKIEWICZ, A. (2026). Neuroprotective and pro-cognitive effects of Rosmarinus officinalis L. extracts and its biologically active compounds on induced neurodegenerative and neuroinflammatory processes in vitro and in vivo in context of Alzheimer’s disease. Current knowledge. Herba Polonica, 72(2), 73-98. https://doi.org/10.5604/01.3001.0055.7332
Vancouver
OŻAROWSKI M, KARPIŃSKI T, STYSZYŃSKI F, URBANIAK A, GRZYWNA W, CHAVES DSDA, et al. Neuroprotective and pro-cognitive effects of Rosmarinus officinalis L. extracts and its biologically active compounds on induced neurodegenerative and neuroinflammatory processes in vitro and in vivo in context of Alzheimer’s disease. Current knowledge. Herba Polonica. 2026;72(2):73-98. doi:10.5604/01.3001.0055.7332
BibTeX
@article{OAROWSKI2026,
author = {OŻAROWSKI, MARCIN and KARPIŃSKI, TOMASZ and STYSZYŃSKI, FRANCISZEK and URBANIAK, AGATA and GRZYWNA, WOJCIECH and CHAVES, DOUGLAS SIQUEIRA DE ALMEIDA and SEREMAK-MROZIKIEWICZ, AGNIESZKA},
title = {Neuroprotective and pro-cognitive effects of Rosmarinus officinalis L. extracts and its biologically active compounds on induced neurodegenerative and neuroinflammatory processes in vitro and in vivo in context of Alzheimer’s disease. Current knowledge},
journal = {Herba Polonica},
year = {2026},
volume = {72},
number = {2},
pages = {73--98},
doi = {10.5604/01.3001.0055.7332}
}
EUVIMED